120 related articles for article (PubMed ID: 3391630)
1. Allopurinol kinetics after massive overdosage.
Ferner RE; Simmonds HA; Bateman DN
Hum Toxicol; 1988 May; 7(3):293-4. PubMed ID: 3391630
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and pharmacodynamics of allopurinol in elderly and young subjects.
Turnheim K; Krivanek P; Oberbauer R
Br J Clin Pharmacol; 1999 Oct; 48(4):501-9. PubMed ID: 10583019
[TBL] [Abstract][Full Text] [Related]
3. Plasma oxipurinol concentrations during allopurinol therapy.
Emmerson BT; Gordon RB; Cross M; Thomson DB
Br J Rheumatol; 1987 Dec; 26(6):445-9. PubMed ID: 3690140
[TBL] [Abstract][Full Text] [Related]
4. [A study on treatment of hyperuricemia--effects and kinetics of allopurinol and oxipurinol].
Hosoya T; Ichida K; Tabe A; Sakai O
Ryumachi; 1991 Feb; 31(1):28-35. PubMed ID: 1857993
[TBL] [Abstract][Full Text] [Related]
5. Disposition and uric acid lowering effect of oxipurinol: comparison of different oxipurinol formulations and allopurinol in healthy individuals.
Walter-Sack I; de Vries JX; Kutschker C; Ittensohn A; Voss A
Eur J Clin Pharmacol; 1995; 49(3):215-20. PubMed ID: 8665998
[TBL] [Abstract][Full Text] [Related]
6. High-performance liquid chromatography with polarographic and voltammetric anodic detection: simultaneous determination of allopurinol, oxipurinol and uric acid in body fluids.
Palmisano F; Desimoni E; Zambonin PG
J Chromatogr; 1984 Mar; 306():205-14. PubMed ID: 6715459
[TBL] [Abstract][Full Text] [Related]
7. Allopurinol metabolism in a patient with xanthine oxidase deficiency.
Yamanaka H; Nishioka K; Suzuki T; Kohno K
Ann Rheum Dis; 1983 Dec; 42(6):684-6. PubMed ID: 6689118
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of allopurinol and its metabolite oxypurinol after oral administration of allopurinol alone or associated with benzbromarone in man. Simultaneous assay of hypoxanthine and xanthine by gas chromatography-mass spectrometry.
Lartigue-Mattei C; Chabard JL; Ristori JM; Bussiere JL; Bargnoux H; Petit J; Berger JA
Fundam Clin Pharmacol; 1991; 5(7):621-33. PubMed ID: 1778540
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous determination of allopurinol and oxipurinol in biological fluids by mass fragmentography.
Lartigue-Mattei C; Chabard JL; Bargnoux H; Petit J; Berger JA
J Chromatogr; 1982 Apr; 229(1):211-6. PubMed ID: 7085828
[No Abstract] [Full Text] [Related]
10. [The clinical pharmacokinetics of allopurinol. 2. Allopurinol/oxypurinol pharmacokinetics following allopurinol in single doses and multiple application].
Fenner H; Schiemann O; Gikalov I
Arzneimittelforschung; 1985; 35(7):1093-6. PubMed ID: 4052144
[TBL] [Abstract][Full Text] [Related]
11. Allopurinol: a comparative study of the bioavailability and effect on plasma uric acid of two products in tablet form.
Nissen P; Pedersen L
Biopharm Drug Dispos; 1985; 6(4):441-6. PubMed ID: 4084669
[TBL] [Abstract][Full Text] [Related]
12. Allopurinol dosage selection: relationships between dose and plasma oxipurinol and urate concentrations and urinary urate excretion.
Day RO; Miners JO; Birkett DJ; Whitehead A; Naidoo D; Hayes J; Savdie E
Br J Clin Pharmacol; 1988 Oct; 26(4):423-8. PubMed ID: 3190992
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous liquid chromatography of 5-fluorouracil, uridine, hypoxanthine, xanthine, uric acid, allopurinol, and oxipurinol in plasma.
Wung WE; Howell SB
Clin Chem; 1980 Nov; 26(12):1704-8. PubMed ID: 7428153
[TBL] [Abstract][Full Text] [Related]
14. The effect of benzbromarone on allopurinol/oxypurinol kinetics in patients with gout.
Müller FO; Schall R; Groenewoud G; Hundt HK; van der Merwe JC; van Dyk M
Eur J Clin Pharmacol; 1993; 44(1):69-72. PubMed ID: 8436158
[TBL] [Abstract][Full Text] [Related]
15. [Studies on purine-pyrimidine metabolism (1)--Quantitation of purine-pyrimidine metabolites and allopurinol-oxipurinol in biological fluids].
Hiroshige K; Kunifuji Y; Takasugi M; Kuroiwa A
J UOEH; 1992 Sep; 14(3):211-8. PubMed ID: 1410939
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics of injectable allopurinol in newborns with the hypoplastic left heart syndrome.
McGaurn SP; Davis LE; Krawczeniuk MM; Murphy JD; Jacobs ML; Norwood WI; Clancy RR
Pediatrics; 1994 Dec; 94(6 Pt 1):820-3. PubMed ID: 7970996
[TBL] [Abstract][Full Text] [Related]
17. Determination of allopurinol and oxipurinol in biological fluids by high-performance liquid chromatography.
Breithaupt H; Goebel G
J Chromatogr; 1981 Nov; 226(1):237-42. PubMed ID: 7320148
[No Abstract] [Full Text] [Related]
18. Uric acid lowering effect of oxipurinol sodium in hyperuricemic patients - therapeutic equivalence to allopurinol.
Walter-Sack I; de Vries JX; Ernst B; Frei M; Kolb S; Kosmowski J; Priebe U; Schroder HE; Slotty C; Voss A; Weber A; Wegscheider K
J Rheumatol; 1996 Mar; 23(3):498-501. PubMed ID: 8832991
[TBL] [Abstract][Full Text] [Related]
19. The determination of allopurinol and oxipurinol in human plasma and urine.
Brown M; Bye A
J Chromatogr; 1977 Mar; 143(2):195-202. PubMed ID: 838831
[TBL] [Abstract][Full Text] [Related]
20. Two siblings with classical xanthinuria type 1: significance of allopurinol loading test.
Ichida K; Yoshida M; Sakuma R; Hosoya T
Intern Med; 1998 Jan; 37(1):77-82. PubMed ID: 9510406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
